ID MYORG_HUMAN Reviewed; 714 AA. AC Q6NSJ0; Q5T587; Q5T588; Q9ULQ9; DT 24-JUL-2007, integrated into UniProtKB/Swiss-Prot. DT 24-JUL-2007, sequence version 2. DT 27-MAR-2024, entry version 145. DE RecName: Full=Myogenesis-regulating glycosidase {ECO:0000312|HGNC:HGNC:19918}; DE EC=3.2.1.-; DE AltName: Full=Uncharacterized family 31 glucosidase KIAA1161; GN Name=MYORG {ECO:0000312|HGNC:HGNC:19918}; Synonyms=KIAA1161; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164053; DOI=10.1038/nature02465; RA Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., RA Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., RA Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., RA Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., RA Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y., RA Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., RA Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E., RA Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M., RA Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J., RA Frankish A., Frankland J.A., French L., Fricker D.G., Garner P., RA Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S., RA Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E., RA Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D., RA Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E., RA Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K., RA Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S., RA Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J., RA Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E., RA McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V., RA Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S., RA Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K., RA Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J., RA Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., RA West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L., RA Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M., RA Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J., RA Dunham I.; RT "DNA sequence and analysis of human chromosome 9."; RL Nature 429:369-374(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ILE-4 AND GLU-53. RC TISSUE=Placenta; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 35-714, AND VARIANT GLU-53. RC TISSUE=Brain; RX PubMed=10574461; DOI=10.1093/dnares/6.5.329; RA Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.; RT "Characterization of cDNA clones selected by the GeneMark analysis from RT size-fractionated cDNA libraries from human brain."; RL DNA Res. 6:329-336(1999). RN [4] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-250. RC TISSUE=Liver; RX PubMed=19159218; DOI=10.1021/pr8008012; RA Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; RT "Glycoproteomics analysis of human liver tissue by combination of multiple RT enzyme digestion and hydrazide chemistry."; RL J. Proteome Res. 8:651-661(2009). RN [5] RP SUBCELLULAR LOCATION, FUNCTION, AND MUTAGENESIS OF ASP-463. RX PubMed=19706595; DOI=10.1074/jbc.m109.034041; RA Datta K., Guan T., Gerace L.; RT "NET37, a nuclear envelope transmembrane protein with glycosidase homology, RT is involved in myoblast differentiation."; RL J. Biol. Chem. 284:29666-29676(2009). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [7] RP SUBCELLULAR LOCATION, INVOLVEMENT IN IBGC7, AND VARIANTS IBGC7 VAL-35; RP 75-TRP--SER-714 DEL; LEU-ALA-PHE-ARG-116 INS; 203-GLN--SER-714 DEL; RP LEU-232; LEU-261; 365-PHE-ASP-366 DEL; GLY-441 AND 443-TRP--SER-714 DEL. RX PubMed=29910000; DOI=10.1016/j.neuron.2018.05.037; RA Yao X.P., Cheng X., Wang C., Zhao M., Guo X.X., Su H.Z., Lai L.L., RA Zou X.H., Chen X.J., Zhao Y., Dong E.L., Lu Y.Q., Wu S., Li X., Fan G., RA Yu H., Xu J., Wang N., Xiong Z.Q., Chen W.J.; RT "Biallelic mutations in MYORG cause autosomal recessive primary familial RT brain calcification."; RL Neuron 98:1116-1123(2018). RN [8] RP INVOLVEMENT IN IBGC7, AND VARIANT IBGC7 ASP-354 DEL. RX PubMed=30656188; DOI=10.1002/acn3.684; RA Arkadir D., Lossos A., Rahat D., Abu Snineh M., Schueler-Furman O., RA Nitschke S., Minassian B.A., Sadaka Y., Lerer I., Tabach Y., Meiner V.; RT "MYORG is associated with recessive primary familial brain calcification."; RL Ann. Clin. Transl. Neurol. 6:106-113(2019). RN [9] RP INVOLVEMENT IN IBGC7, AND VARIANTS IBGC7 GLU-64; ARG-113; RP LEU-ALA-PHE-ARG-116 INS; ALA-236 INS; CYS-249; ASP-373; HIS-434; RP 445-GLN--SER-714 DEL; ASN-476; SER-513 DEL; TRP-611; PRO-622; THR-656 AND RP GLN-660. RX PubMed=31009047; DOI=10.1093/brain/awz095; RG French PFBC study group; RA Grangeon L., Wallon D., Charbonnier C., Quenez O., Richard A.C., RA Rousseau S., Budowski C., Lebouvier T., Corbille A.G., Vidailhet M., RA Meneret A., Roze E., Anheim M., Tranchant C., Favrole P., Antoine J.C., RA Defebvre L., Ayrignac X., Labauge P., Pariente J., Clanet M., Maltete D., RA Rovelet-Lecrux A., Boland A., Deleuze J.F., Frebourg T., Hannequin D., RA Campion D., Nicolas G.; RT "Biallelic MYORG mutation carriers exhibit primary brain calcification with RT a distinct phenotype."; RL Brain 142:1573-1586(2019). RN [10] RP INVOLVEMENT IN IBGC7, AND VARIANT IBGC7 445-GLN--SER-714 DEL. RX PubMed=30460687; DOI=10.1111/cge.13467; RA Peng Y., Wang P., Chen Z., Jiang H.; RT "A novel mutation in MYORG causes primary familial brain calcification with RT central neuropathic pain."; RL Clin. Genet. 95:433-435(2019). RN [11] RP INVOLVEMENT IN IBGC7, AND VARIANTS IBGC7 LEU-ALA-PHE-ARG-116 INS; RP 143-LEU--ILE-147 DEL; CYS-229 AND 477-TYR--SER-714 DEL. RX PubMed=30589467; DOI=10.1002/mds.27582; RA Chen Y., Fu F., Chen S., Cen Z., Tang H., Huang J., Xie F., Zheng X., RA Yang D., Wang H., Huang X., Zhang Y., Zhou Y., Liu J.Y., Luo W.; RT "Evaluation of MYORG mutations as a novel cause of primary familial brain RT calcification."; RL Mov. Disord. 34:291-297(2019). RN [12] RP INVOLVEMENT IN IBGC7. RX PubMed=30895394; DOI=10.1007/s10048-019-00571-8; RA Ramos E.M., Roca A., Chumchim N., Dokuru D.R., Van Berlo V., De Michele G., RA Lieto M., Tedeschi E., De Michele G., Coppola G.; RT "Primary familial brain calcification caused by a novel homozygous MYORG RT mutation in a consanguineous Italian family."; RL Neurogenetics 20:99-102(2019). CC -!- FUNCTION: Putative glycosidase. Promotes myogenesis by activating AKT CC signaling through the maturation and secretion of IGF2. CC {ECO:0000250|UniProtKB:Q69ZQ1}. CC -!- SUBUNIT: Interacts with IGF2; this interaction is required for IGF2 CC secretion. {ECO:0000250|UniProtKB:Q69ZQ1}. CC -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000250|UniProtKB:Q69ZQ1}; CC Single-pass type II membrane protein {ECO:0000250|UniProtKB:Q69ZQ1}. CC Endoplasmic reticulum membrane {ECO:0000269|PubMed:29910000}; Single- CC pass type II membrane protein {ECO:0000250|UniProtKB:Q69ZQ1}. Note=Only CC a minor fraction is present in the peripheral endoplasmic reticulum. CC {ECO:0000250|UniProtKB:Q69ZQ1}. CC -!- DISEASE: Basal ganglia calcification, idiopathic, 7, autosomal CC recessive (IBGC7) [MIM:618317]: A form of basal ganglia calcification, CC a genetically heterogeneous condition characterized by symmetric CC calcification in the basal ganglia and other brain regions. Affected CC individuals can either be asymptomatic or show a wide spectrum of CC neuropsychiatric symptoms, including parkinsonism, dystonia, tremor, CC ataxia, dementia, psychosis, seizures, and chronic headache. Serum CC levels of calcium, phosphate, alkaline phosphatase and parathyroid CC hormone are normal. The neuropathological hallmark of the disease is CC vascular and pericapillary calcification, mainly of calcium phosphate, CC in the affected brain areas. {ECO:0000269|PubMed:29910000, CC ECO:0000269|PubMed:30460687, ECO:0000269|PubMed:30589467, CC ECO:0000269|PubMed:30656188, ECO:0000269|PubMed:30895394, CC ECO:0000269|PubMed:31009047}. Note=The disease is caused by variants CC affecting the gene represented in this entry. CC -!- MISCELLANEOUS: The requirement of the predicted catalytic residue Asp- CC 463 to support myogenic function strongly suggests that MYORG is an CC enzymatically active glycosidase in vivo, even if concrete experimental CC proof for enzymatic activity is still missing. CC {ECO:0000305|PubMed:19706595}. CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 31 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AL356494; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC070098; AAH70098.1; -; mRNA. DR EMBL; BC110493; AAI10494.1; -; mRNA. DR EMBL; AB032987; BAA86475.2; -; mRNA. DR CCDS; CCDS78391.1; -. DR RefSeq; NP_065753.2; NM_020702.4. DR RefSeq; XP_011516268.1; XM_011517966.2. DR RefSeq; XP_016870419.1; XM_017014930.1. DR PDB; 7QQF; X-ray; 2.43 A; A/B/C/D=80-714. DR PDB; 7QQG; X-ray; 2.43 A; A/B/C/D=80-714. DR PDB; 7QQH; X-ray; 2.25 A; A/B/C/D=80-714. DR PDBsum; 7QQF; -. DR PDBsum; 7QQG; -. DR PDBsum; 7QQH; -. DR AlphaFoldDB; Q6NSJ0; -. DR SMR; Q6NSJ0; -. DR BioGRID; 121532; 58. DR IntAct; Q6NSJ0; 12. DR STRING; 9606.ENSP00000297625; -. DR CAZy; GH31; Glycoside Hydrolase Family 31. DR GlyConnect; 1882; 2 N-Linked glycans (1 site). DR GlyCosmos; Q6NSJ0; 3 sites, 2 glycans. DR GlyGen; Q6NSJ0; 5 sites, 2 N-linked glycans (1 site). DR iPTMnet; Q6NSJ0; -. DR PhosphoSitePlus; Q6NSJ0; -. DR SwissPalm; Q6NSJ0; -. DR BioMuta; MYORG; -. DR DMDM; 158563982; -. DR EPD; Q6NSJ0; -. DR jPOST; Q6NSJ0; -. DR MassIVE; Q6NSJ0; -. DR MaxQB; Q6NSJ0; -. DR PaxDb; 9606-ENSP00000297625; -. DR PeptideAtlas; Q6NSJ0; -. DR ProteomicsDB; 66636; -. DR Pumba; Q6NSJ0; -. DR Antibodypedia; 55615; 61 antibodies from 12 providers. DR DNASU; 57462; -. DR Ensembl; ENST00000297625.8; ENSP00000297625.8; ENSG00000164976.9. DR GeneID; 57462; -. DR KEGG; hsa:57462; -. DR MANE-Select; ENST00000297625.8; ENSP00000297625.8; NM_020702.5; NP_065753.2. DR UCSC; uc033cpb.2; human. DR AGR; HGNC:19918; -. DR CTD; 57462; -. DR DisGeNET; 57462; -. DR GeneCards; MYORG; -. DR HGNC; HGNC:19918; MYORG. DR HPA; ENSG00000164976; Tissue enhanced (skeletal). DR MalaCards; MYORG; -. DR MIM; 618255; gene. DR MIM; 618317; phenotype. DR neXtProt; NX_Q6NSJ0; -. DR OpenTargets; ENSG00000164976; -. DR Orphanet; 1980; Bilateral striopallidodentate calcinosis. DR PharmGKB; PA134929853; -. DR VEuPathDB; HostDB:ENSG00000164976; -. DR eggNOG; KOG1065; Eukaryota. DR GeneTree; ENSGT00940000161008; -. DR HOGENOM; CLU_008294_0_0_1; -. DR InParanoid; Q6NSJ0; -. DR OMA; AFFTWVH; -. DR OrthoDB; 2725689at2759; -. DR PhylomeDB; Q6NSJ0; -. DR TreeFam; TF324266; -. DR PathwayCommons; Q6NSJ0; -. DR SignaLink; Q6NSJ0; -. DR BioGRID-ORCS; 57462; 9 hits in 392 CRISPR screens. DR ChiTaRS; MYORG; human. DR GenomeRNAi; 57462; -. DR Pharos; Q6NSJ0; Tbio. DR PRO; PR:Q6NSJ0; -. DR Proteomes; UP000005640; Chromosome 9. DR RNAct; Q6NSJ0; Protein. DR Bgee; ENSG00000164976; Expressed in ventricular zone and 122 other cell types or tissues. DR ExpressionAtlas; Q6NSJ0; baseline and differential. DR GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB. DR GO; GO:0031965; C:nuclear membrane; ISS:UniProtKB. DR GO; GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro. DR GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro. DR GO; GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; ISS:UniProtKB. DR GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:UniProtKB. DR GO; GO:0048741; P:skeletal muscle fiber development; IMP:UniProtKB. DR CDD; cd06592; GH31_NET37; 1. DR Gene3D; 3.20.20.80; Glycosidases; 1. DR Gene3D; 2.60.40.1180; Golgi alpha-mannosidase II; 1. DR InterPro; IPR048395; Glyco_hydro_31_C. DR InterPro; IPR000322; Glyco_hydro_31_TIM. DR InterPro; IPR013780; Glyco_hydro_b. DR InterPro; IPR017853; Glycoside_hydrolase_SF. DR PANTHER; PTHR43053; GLYCOSIDASE FAMILY 31; 1. DR PANTHER; PTHR43053:SF7; MYOGENESIS-REGULATING GLYCOSIDASE; 1. DR Pfam; PF01055; Glyco_hydro_31_2nd; 2. DR Pfam; PF21365; Glyco_hydro_31_3rd; 1. DR SUPFAM; SSF51445; (Trans)glycosidases; 1. DR SUPFAM; SSF51011; Glycosyl hydrolase domain; 1. DR Genevisible; Q6NSJ0; HS. PE 1: Evidence at protein level; KW 3D-structure; Disease variant; Endoplasmic reticulum; Glycoprotein; KW Glycosidase; Hydrolase; Membrane; Nucleus; Reference proteome; KW Signal-anchor; Transmembrane; Transmembrane helix. FT CHAIN 1..714 FT /note="Myogenesis-regulating glycosidase" FT /id="PRO_0000295752" FT TOPO_DOM 1..56 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 57..77 FT /note="Helical; Signal-anchor for type II membrane protein" FT /evidence="ECO:0000255" FT TOPO_DOM 78..714 FT /note="Extracellular" FT /evidence="ECO:0000255" FT ACT_SITE 463 FT /evidence="ECO:0000250" FT ACT_SITE 466 FT /evidence="ECO:0000250" FT ACT_SITE 528 FT /note="Proton donor" FT /evidence="ECO:0000250" FT CARBOHYD 240 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 250 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19159218" FT CARBOHYD 511 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VARIANT 4 FT /note="N -> I (in dbSNP:rs2297776)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_033359" FT VARIANT 35 FT /note="M -> V (in IBGC7; dbSNP:rs765483979)" FT /evidence="ECO:0000269|PubMed:29910000" FT /id="VAR_081940" FT VARIANT 53 FT /note="D -> E (in dbSNP:rs4879781)" FT /evidence="ECO:0000269|PubMed:10574461, FT ECO:0000269|PubMed:15489334" FT /id="VAR_033360" FT VARIANT 64 FT /note="G -> E (in IBGC7; uncertain significance; FT dbSNP:rs756514041)" FT /evidence="ECO:0000269|PubMed:31009047" FT /id="VAR_081941" FT VARIANT 75..714 FT /note="Missing (in IBGC7)" FT /evidence="ECO:0000269|PubMed:29910000" FT /id="VAR_081942" FT VARIANT 113 FT /note="L -> R (in IBGC7; uncertain significance; FT dbSNP:rs753277260)" FT /evidence="ECO:0000269|PubMed:31009047" FT /id="VAR_081943" FT VARIANT 116 FT /note="R -> RLAFR (in IBGC7)" FT /evidence="ECO:0000269|PubMed:29910000, FT ECO:0000269|PubMed:30589467, ECO:0000269|PubMed:31009047" FT /id="VAR_081944" FT VARIANT 143..147 FT /note="Missing (in IBGC7; uncertain significance)" FT /evidence="ECO:0000269|PubMed:30589467" FT /id="VAR_081945" FT VARIANT 199 FT /note="R -> S (in dbSNP:rs12377)" FT /id="VAR_033361" FT VARIANT 203..714 FT /note="Missing (in IBGC7)" FT /evidence="ECO:0000269|PubMed:29910000" FT /id="VAR_081946" FT VARIANT 229 FT /note="W -> C (in IBGC7; uncertain significance; FT dbSNP:rs1588004637)" FT /evidence="ECO:0000269|PubMed:30589467" FT /id="VAR_081947" FT VARIANT 232 FT /note="S -> L (in IBGC7; uncertain significance; FT dbSNP:rs757434146)" FT /evidence="ECO:0000269|PubMed:29910000" FT /id="VAR_081948" FT VARIANT 236 FT /note="A -> AA (in IBGC7; uncertain significance)" FT /evidence="ECO:0000269|PubMed:31009047" FT /id="VAR_081949" FT VARIANT 249 FT /note="W -> C (in IBGC7; uncertain significance; FT dbSNP:rs1356560096)" FT /evidence="ECO:0000269|PubMed:31009047" FT /id="VAR_081950" FT VARIANT 261 FT /note="R -> L (in IBGC7; uncertain significance)" FT /evidence="ECO:0000269|PubMed:29910000" FT /id="VAR_081951" FT VARIANT 354 FT /note="Missing (in IBGC7; uncertain significance; FT dbSNP:rs1180204613)" FT /evidence="ECO:0000269|PubMed:30656188" FT /id="VAR_081952" FT VARIANT 365..366 FT /note="Missing (in IBGC7; uncertain significance)" FT /evidence="ECO:0000269|PubMed:29910000" FT /id="VAR_081953" FT VARIANT 373 FT /note="A -> D (in IBGC7; uncertain significance; FT dbSNP:rs1588004082)" FT /evidence="ECO:0000269|PubMed:31009047" FT /id="VAR_081954" FT VARIANT 385 FT /note="F -> Y (in dbSNP:rs7852399)" FT /id="VAR_033362" FT VARIANT 434 FT /note="D -> H (in IBGC7; uncertain significance; FT dbSNP:rs916933188)" FT /evidence="ECO:0000269|PubMed:31009047" FT /id="VAR_081955" FT VARIANT 441 FT /note="R -> G (in IBGC7; dbSNP:rs749427106)" FT /evidence="ECO:0000269|PubMed:29910000" FT /id="VAR_081956" FT VARIANT 443..714 FT /note="Missing (in IBGC7)" FT /evidence="ECO:0000269|PubMed:29910000" FT /id="VAR_081957" FT VARIANT 445..714 FT /note="Missing (in IBGC7)" FT /evidence="ECO:0000269|PubMed:30460687, FT ECO:0000269|PubMed:31009047" FT /id="VAR_081958" FT VARIANT 476 FT /note="T -> N (in IBGC7; uncertain significance; FT dbSNP:rs769099047)" FT /evidence="ECO:0000269|PubMed:31009047" FT /id="VAR_081959" FT VARIANT 477..714 FT /note="Missing (in IBGC7)" FT /evidence="ECO:0000269|PubMed:30589467" FT /id="VAR_081960" FT VARIANT 513 FT /note="Missing (in IBGC7; uncertain significance)" FT /evidence="ECO:0000269|PubMed:31009047" FT /id="VAR_081961" FT VARIANT 611 FT /note="R -> W (in IBGC7; uncertain significance; FT dbSNP:rs536187898)" FT /evidence="ECO:0000269|PubMed:31009047" FT /id="VAR_081962" FT VARIANT 622 FT /note="L -> P (in IBGC7; uncertain significance; FT dbSNP:rs1239594469)" FT /evidence="ECO:0000269|PubMed:31009047" FT /id="VAR_081963" FT VARIANT 656 FT /note="I -> T (in IBGC7; uncertain significance; FT dbSNP:rs370944350)" FT /evidence="ECO:0000269|PubMed:31009047" FT /id="VAR_081964" FT VARIANT 660 FT /note="L -> Q (in IBGC7; uncertain significance; FT dbSNP:rs1588002920)" FT /evidence="ECO:0000269|PubMed:31009047" FT /id="VAR_081965" FT MUTAGEN 463 FT /note="D->A: Does not change nuclear membrane localization. FT Does not rescue the myogenetic defect induced by depletion FT of endogenous MYORG." FT /evidence="ECO:0000269|PubMed:19706595" FT STRAND 93..96 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 99..103 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 109..117 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 122..124 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 125..128 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 131..137 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 142..153 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 156..164 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 166..168 FT /evidence="ECO:0007829|PDB:7QQF" FT STRAND 172..177 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 185..189 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 202..208 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 214..216 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 218..220 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 223..231 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 234..239 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 245..250 FT /evidence="ECO:0007829|PDB:7QQH" FT TURN 251..254 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 255..260 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 263..266 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 278..285 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 289..300 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 310..313 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 317..320 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 321..324 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 325..327 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 330..342 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 350..352 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 357..359 FT /evidence="ECO:0007829|PDB:7QQH" FT TURN 367..369 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 373..382 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 387..391 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 393..396 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 402..408 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 417..420 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 423..425 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 428..433 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 438..455 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 459..462 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 467..469 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 485..491 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 492..500 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 502..504 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 506..508 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 514..517 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 523..526 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 531..533 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 534..543 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 548..550 FT /evidence="ECO:0007829|PDB:7QQH" FT TURN 564..567 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 571..581 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 584..586 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 588..591 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 593..595 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 598..613 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 615..629 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 633..635 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 637..639 FT /evidence="ECO:0007829|PDB:7QQH" FT HELIX 645..649 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 654..656 FT /evidence="ECO:0007829|PDB:7QQH" FT TURN 657..659 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 660..663 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 671..677 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 679..684 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 694..701 FT /evidence="ECO:0007829|PDB:7QQH" FT STRAND 708..713 FT /evidence="ECO:0007829|PDB:7QQH" SQ SEQUENCE 714 AA; 81087 MW; D17E4A75A81DBB46 CRC64; MLQNPQEKSQ AYPRRRRPGC YAYRQNPEAI AAAAMYTFLP DNFSPAKPKP SKDLKPLLGS AVLGLLLVLA AVVAWCYYSV SLRKAERLRA ELLDLKAGGF SIRNQKGEQV FRLAFRSGAL DLDSCSRDGA LLGCSLTADG LPLHFFIQTV RPKDTVMCYR VRWEEAAPGR AVEHAMFLGD AAAHWYGGAE MRTQHWPIRL DGQQEPQPFV TSDVYSSDAA FGGILERYWL SSRAAAIKVN DSVPFHLGWN STERSLRLQA RYHDTPYKPP AGRAAAPELS YRVCVGSDVT SIHKYMVRRY FNKPSRVPAP EAFRDPIWST WALYGRAVDQ DKVLRFAQQI RLHHFNSSHL EIDDMYTPAY GDFDFDEVKF PNASDMFRRL RDAGFRVTLW VHPFVNYNSS RFGEGVEREL FVREPTGRLP ALVRWWNGIG AVLDFTHPKA RDWFQGHLRR LRSRYSVASF KFDAGEVSYL PRDFSTYRPL PDPSVWSRRY TEMALPFFSL AEVRVGYQSQ NISCFFRLVD RDSVWGYDLG LRSLIPAVLT VSMLGYPFIL PDMVGGNAVP QRTAGGDVPE RELYIRWLEV AAFMPAMQFS IPPWRYDAEV VAIAQKFAAL RASLVAPLLL ELAGEVTDTG DPIVRPLWWI APGDETAHRI DSQFLIGDTL LVAPVLEPGK QERDVYLPAG KWRSYKGELF DKTPVLLTDY PVDLDEIAYF TWAS //